Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 436

1.

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.

Rello J, Ulldemolins M, Lisboa T, Koulenti D, Mañez R, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E; EU-VAP/CAP Study Group.

Eur Respir J. 2011 Jun;37(6):1332-9. doi: 10.1183/09031936.00093010. Epub 2010 Sep 16.

2.
3.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

4.

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.

Arnold HM, Sawyer AM, Kollef MH.

Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.

5.

High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, So TM, Yasin RM, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Kim MJ, Choi JY, Kim SI, Ko KS, Kang CI, Peck KR; Asian Network for Surveillance of Resistant Pathogens Study Group.

Am J Respir Crit Care Med. 2011 Dec 15;184(12):1409-17. doi: 10.1164/rccm.201102-0349OC. Epub 2011 Sep 15.

PMID:
21920919
7.

Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M, Gando S, Sosa C, Baquero S, Llerena C, Petrati C, Apezteguia C.

Eur Respir J. 2007 Aug;30(2):307-13. Epub 2007 May 15.

8.

Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units.

Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J; EU-VAP/CAP Study Group.

Crit Care Med. 2009 Aug;37(8):2360-8. doi: 10.1097/CCM.0b013e3181a037ac.

PMID:
19531951
10.

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia.

Fowler RA, Flavin KE, Barr J, Weinacker AB, Parsonnet J, Gould MK.

Chest. 2003 Mar;123(3):835-44.

PMID:
12628886
11.

Antibiotic prescription in intensive care units in Latin America.

Curcio DJ; On behaf of the Latin American antibiotic use in intensive care unit group.

Rev Argent Microbiol. 2011 Jul-Sep;43(3):203-11. doi: 10.1590/S0325-75412011000300007.

12.

Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.

Weiss E, Dahmani S, Bert F, Janny S, Sommacale D, Dondero F, Francoz C, Belghiti J, Mantz J, Paugam-Burtz C.

Liver Transpl. 2010 Oct;16(10):1178-85. doi: 10.1002/lt.22132.

13.

Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance.

Medell M, Hart M, Duquesne A, Espinosa F, Valdés R.

MEDICC Rev. 2013 Apr;15(2):26-9.

14.

Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.

Dupont H, Mentec H, Sollet JP, Bleichner G.

Intensive Care Med. 2001 Feb;27(2):355-62.

PMID:
11396279
15.

Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study.

Magret M, Lisboa T, Martin-Loeches I, Máñez R, Nauwynck M, Wrigge H, Cardellino S, Díaz E, Koulenti D, Rello J; EU-VAP/CAP Study Group.

Crit Care. 2011;15(1):R62. doi: 10.1186/cc10036. Epub 2011 Feb 16.

16.

Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A.

Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.

PMID:
24613422
17.

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes.

Piskin N, Aydemir H, Oztoprak N, Akduman D, Comert F, Kokturk F, Celebi G.

BMC Infect Dis. 2012 Oct 24;12:268. doi: 10.1186/1471-2334-12-268.

18.

[Actualities of adults' ventilator-associated pneumonia].

Svediene S, Ivaskevicius J.

Medicina (Kaunas). 2006;42(2):91-7. Review. Lithuanian.

19.

Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.

Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL.

Pharmacotherapy. 2010 May;30(5):453-62. doi: 10.1592/phco.30.5.453.

PMID:
20411997
20.

Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand.

Reechaipichitkul W, Phondongnok S, Bourpoern J, Chaimanee P.

Southeast Asian J Trop Med Public Health. 2013 May;44(3):490-502.

PMID:
24050082

Supplemental Content

Support Center